References
- DavisJMChenNGlickIDA meta-analysis of the efficacy of second-generation antipsychoticsArch Gen Psychiatry200360655356412796218
- SchneiderCCorrigallRHayesDKyriakopoulosMFrangouSSystematic review of the efficacy and tolerability of clozapine in the treatment of youth with early onset schizophreniaEur Psychiatry201429111024119631
- HaringCMeiseUHumpelCSariaAFleischhackerWWHinterhuberHDose-related plasma levels of clozapine: influence of smoking behaviour, sex and agePsychopharmacology198999SupplS38S402813665
- CentorrinoFBaldessariniRJKandoJCFrankenburgFRVolpicelliSAFloodJGClozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patientsJ Clin Psychopharmacol19941421191258195452
- PerryPJBeverKAArndtSCombsMDRelationship between patient variables and plasma clozapine concentrations: a dosing nomogramBiol Psychiatry19984487337389798077
- Rostami-HodjeganAAminAMSpencerEPLennardMSTuckerGTFlanaganRJInfluence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patientsJ Clin Psychopharmacol2004241707814709950
- AldonzaMBHongJYAlinsugMVSongJLeeSKMultiplicity of acquired cross-resistance in paclitaxel-resistant cancer cells is associated with feedback control of TUBB3 via FOXO3a-mediated ABCB1 regulationOncotarget2016723343953441927284014
- ZairZMSingerDREfflux transporter variants as predictors of drug toxicity in lung cancer patients: systematic review and meta-analysisPharmacogenomics20161791089111227269636
- YinJZhangJMultidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical applicationZhong Nan Da Xue Xue Bao Yi Xue Ban2011361092793822086004
- MunozMHendersonMHaberMNorrisMRole of the MRP1/ABCC1 multidrug transporter protein in cancerIUBMB Life2007591275275718085475
- Anil YagciogluAEIlhanBCGoktasMTBabaogluMOUzEYaziciMKAgranulocytosis related to clozapine in monozygotic twins and association with allelic variants of multidrug resistance gene MDR1J Clin Psychopharmacol201131224724921364339
- van der WeideKLooversHPondmanKGenetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric populationPharmacogenomics J Epub2016510
- ConsoliGLastellaMCiapparelliAABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patientsPharmacogenomics20091081267127619663671
- Jaquenoud SirotEKnezevicBMorenaGPABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapineJ Clin Psychopharmacol200929431932619593168
- LeeSTRyuSKimSRAssociation study of 27 annotated genes for clozapine pharmacogenetics: validation of preexisting studies and identification of a new candidate gene, ABCB1, for treatment responseJ Clin Psychopharmacol201232444144822722500
- R Development Core TeamR: A Language and Environment for Statistical ComputingVienna, AustriaR Foundation for Statistical Computing2011
- TekCKucukgoncuSGuloksuzSWoodsSWSrihariVHAnnamalaiAAntipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medicationsEarly Interv Psychiatry201610319320225962699
- MeltzerHYAn overview of the mechanism of action of clozapineJ Clin Psychiatry199455Suppl B47527961573
- EapCBBochudMElstonRCCYP3A5 and ABCB1 genes influence blood pressure and response to treatment, and their effect is modified by saltHypertension20074951007101417372036
- ZhangXWYangJLLiangWGenetic association study of ABCB1 gene polymorphisms with hypertension in Han Chinese populationEur Rev Med Pharmacol Sci201620173661367127649668